IP
70
2
MRO
55
3
EXC
54
-2
MTCH
37
7
TRV
53
-3
ILMN
32
-3
RRC
63
3
TXT
48
2
IVZ
46
3
WMT
74
2
CSCO
63
2
HRL
39
15
JPM
63
-4
BIIB
26
2
CSX
51
-2
LUV
39
-5
QRVO
6
2
ORLY
53
-3
BAC
50
-3
VLO
40
-2
IP
70
2
MRO
55
3
EXC
54
-2
MTCH
37
7
TRV
53
-3
ILMN
32
-3
RRC
63
3
TXT
48
2
IVZ
46
3
WMT
74
2
CSCO
63
2
HRL
39
15
JPM
63
-4
BIIB
26
2
CSX
51
-2
LUV
39
-5
QRVO
6
2
ORLY
53
-3
BAC
50
-3
VLO
40
-2
Financhill
Back

Globalstar 10K Form

Buy
53

GSAT
Globalstar

Last Price:
1.76
Seasonality Move:
45.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GSAT News And Ratings

See the #1 stock for the next 7 days that we like better than GSAT

GSAT Financial Statistics

Sales & Book Value

Annual Sales: $223.81M
Cash Flow: $5.48M
Price / Cash Flow: 0
Annual Sales: $0.21
Price / Book: 8.5

Profitability

EPS (TTM): -0.02480
Net Income (TTM): $-28.02M
Gross Margin: $154.34M
Return on Equity: -7.31%
Return on Assets: -3.05%

Globalstar Earnings Forecast

Key Globalstar Financial Ratios

  • The Gross Profit Margin over the past 21 years for GSAT is 68.96%.
  • The Selling, General & Administrative Expenses for GSAT have been equal to 29.47% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 407.60% of Operating Income.
  • The Net Earning history of GSAT is -11.04% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Globalstar Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Diversified Telecommunication Services
Sector: Communication Services
Current Symbol: GSAT
CUSIP: 378973
Website: globalstar.com

Debt

Debt-to-Equity Ratio: 1
Current Ratio: 1.09
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GSAT Technical Analysis vs Fundamental Analysis

Buy
53
Globalstar (GSAT) is a Buy

Is Globalstar a Buy or a Sell?

  • Globalstar stock is rated a Buy
    The current Globalstar [GSAT] share price is $1.77. The Score for GSAT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.